Opportunistic Infections Citation List:
December 25, 2008- January 6, 2009
Opportunistic protozoa (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG, Bordón C, Posner GH, Yolken R, Jones-Brando L.
J Antimicrob Chemother. 2009 Jan;63(1):146-50. Epub 2008 Nov 6.
PMID: 18988681 [PubMed - in process]
Opportunistic Fungi (Cryptococcus, Aspergillus, Candida, Histoplasma)
2. N,N-Dichloroaminosulfonic acids as novel topical antimicrobial agents.
Low E, Nair S, Shiau T, Belisle B, Debabov D, Celeri C, Zuck M, Najafi R, Georgopapadakou N, Jain R.
Bioorg Med Chem Lett. 2009 Jan 1;19(1):196-8. Epub 2008 Oct 31.
PMID: 19010674 [PubMed - in process]
TB (Tuberculosis, Mycobacterium, Avium, Drug Resistant, MAC, MDR)
3. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
Vicente E, Pérez-Silanes S, Lima LM, Ancizu S, Burguete A, Solano B, Villar R, Aldana I, Monge A.
Bioorg Med Chem. 2009 Jan 1;17(1):385-9. Epub 2008 Nov 5.
PMID: 19058970 [PubMed - in process]
4. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H, Wang F, Zhang Y, Huang Q, Xu S, Hu H, Yue J, Wang H.
FEBS J. 2009 Jan;276(1):144-54. Epub 2008 Nov 20.
PMID: 19032598 [PubMed - in process]
5. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
Schott H, Hamprecht K, Schott S, Schott TC, Schwendener RA.
Bioorg Med Chem. 2009 Jan 1;17(1):303-10. Epub 2008 Nov 5.
PMID: 19010684 [PubMed - in process]
6. Antibacterial activity of two limonoids from Swietenia mahagoni against multiple-drug-resistant (MDR) bacterial strains.
Rahman AK, Chowdhury AK, Ali HA, Raihan SZ, Ali MS, Nahar L, Sarker SD.
Nat Med (Tokyo). 2009 Jan;63(1):41-5. Epub 2008 Aug 26.
PMID: 18726560 [PubMed - in process]
7. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.
Senthilkumar P, Dinakaran M, Yogeeswari P, Sriram D, China A, Nagaraja V.
Eur J Med Chem. 2009 Jan;44(1):345-58. Epub 2008 Mar 7.
PMID: 18502542 [PubMed - in process]
8. Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides.
Daryaee F, Kobarfard F, Khalaj A, Farnia P.
Eur J Med Chem. 2009 Jan;44(1):289-95. Epub 2008 Mar 7.
PMID: 18436347 [PubMed - in process]
9. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D, Yogeeswari P, Yelamanchili Priya D.
Biomed Pharmacother. 2009 Jan;63(1):36-9. Epub 2008 Feb 25.
PMID: 18343086 [PubMed - in process]
10. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M, Senthilkumar P, Yogeeswari P, Sriram D.
Biomed Pharmacother. 2009 Jan;63(1):11-8. Epub 2007 Nov 20.
PMID: 18078735 [PubMed - in process]
11. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P, Dinakaran M, Yogeeswari P, China A, Nagaraja V, Sriram D.
Biomed Pharmacother. 2009 Jan;63(1):27-35. Epub 2007 Oct 29.
PMID: 18031974 [PubMed - in process]
Antimicrobials, Antifungals (General)
12. Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines.
Van de Vijver P, Vondenhoff GH, Denivelle S, Rozenski J, Verhaegen J, Van Aerschot A, Herdewijn P.
Bioorg Med Chem. 2009 Jan 1;17(1):260-9. Epub 2008 Nov 27.
PMID: 19070499 [PubMed - in process]
13. Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
Manjula MK, Rai KM, Gaonkar SL, Raveesha KA, Satish S.
Eur J Med Chem. 2009 Jan;44(1):280-8. Epub 2008 Mar 7.
PMID: 18420309 [PubMed - in process]
14. Synthesis and QSAR modeling of 2-acetyl-2-ethoxycarbonyl-1-[4(4'-arylazo)-phenyl]-N,N-dimethylaminophenyl aziridines as potential antibacterial agents.
Sharma P, Kumar A, Upadhyay S, Sahu V, Singh J.
Eur J Med Chem. 2009 Jan;44(1):251-9. Epub 2008 Feb 29.
PMID: 18396359 [PubMed - in process]
15. Isolation, Structure Elucidation, and Biological Activity of Virgineone from Lachnum virgineum Using the Genome-Wide Candida albicans Fitness Test.
Ondeyka J, Harris G, Zink D, Basilio A, Vicente F, Bills G, Platas G, Collado J, González A, Cruz MD, Martin J, Kahn JN, Galuska S, Giacobbe R, Abruzzo G, Hickey E, Liberator P, Jiang B, Xu D, Roemer T, Singh SB.
J Nat Prod. 2008 Dec 30. [Epub ahead of print]
PMID: 19115836 [PubMed - as supplied by publisher]
16. Antifungal and antibacterial activity of the newly synthesized 2-xanthone derivatives.
Marona H, Szkaradek N, Karczewska E, Trojanowska D, Budak A, Bober P, Przepiórka W, Cegla M, Szneler E.
Arch Pharm (Weinheim). 2009 Jan;342(1):9-18.
PMID: 19051197 [PubMed - in process]
17. Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles.
Ryu CK, Lee JY, Jeong SH, Nho JH.
Bioorg Med Chem Lett. 2009 Jan 1;19(1):146-8. Epub 2008 Nov 5.
PMID: 19010669 [PubMed - in process]